Excellent performance for Theranostics sales, with growth of 15.5% Substantial expansion in activity in the United States, materialized by growth of 34.0% Solid performance for sales in France, driven by IVD activity Cash position at…
2020 Situation au 30 Juin 2020(FR) Situation au 31 mai 2020(FR) Situation au 30 avril 2020(FR) Situation au 29 février 2020(FR) Situation au 31 janvier 2020(FR) 2019 Situation au 31 octobre 2019(FR) Situation au 30…
Croissy-Beaubourg, February 19, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, has been actively involved in the establishment and validation of a new World Health…